Molecular characterization of the antithrombin III tours deficiency

Bjork, 1981, The site in human antithrombin for functional proteolytic cleavage by human thrombin, FEBS Lett., 126, 257, 10.1016/0014-5793(81)80255-4

Chandra, 1983, Isolation and sequence characterization of a cDNA clone of human antithrombin III, 80, 1845

Bjork, 1982, Mechanism of the anticoagulant action of heparin, Mol. and Cell. Biochem., 48, 161, 10.1007/BF00421226

Koide, 1984, Antithrombin III Toyama : replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin binding ability, 81, 289

Chang, 1986, Antithrombin III Basel, 261, 1174

Blackburn, 1984, The heparin-binding site of Antithrombin III. Identification of a critical tryptophan in the amino acid sequence, J. Biol. Chem., 259, 939, 10.1016/S0021-9258(17)43548-4

Rosenberg, 1973, The purification and mechanism of action of human antithrombin-heparin cofactor, J. Biol. Chem., 248, 6490, 10.1016/S0021-9258(19)43472-8

Pecon, 1984, Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III, J. Biol. Chem., 259, 935, 10.1016/S0021-9258(17)43547-2

Jorgensen, 1985, Arginine residues are critical for the heparin-cofactor activity of antithrombin III, Biochem. J., 231, 59, 10.1042/bj2310059

Villanueva, 1984, Predictions of the secondary structure of antithrombin III and the location of the heparin-binding site, J. Biol. Chem., 259, 2531, 10.1016/S0021-9258(17)43385-0

FISCHER, A.M., DAUTZENBERG, M.D. and TAPON-BRETAUDIERE, J. Deficits congenitaux en antithrombine III. In: Physiopathologie de la thrombose et de l'hemostase. Progres en hematologie SY. Sultan et A.M. Fischer, eds., Douin, Paris, in the press.

Nagy, 1979, Three types of hereditary antithrombin III deficiency, Thrombos. Haemost., 42, 187

Chasse, 1984, An abnormal plasma antithrombin with no apparent affinity for heparin, Thromb. Res., 34, 297, 10.1016/0049-3848(84)90386-4

Poncz, 1982, Construction of human gene libraries from small amounts of peripheral blood: analysis of B-like globin genes, Hemoglobin, 6, 27, 10.3109/03630268208996930

Southern, 1975, Detection of specific sequences among DNA fragments separated by gel electrophoresis, J. Mol. Biol., 98, 503, 10.1016/S0022-2836(75)80083-0

Huynh-Dinh, 1985, Modified oligonucleotides as alternatives to the synthesis of mixed probes for the screening of cDNA libraries, 82, 7510

Maniatis, 1982, Molecular Cloning

Frischauf, 1983, Lambda replacement vectors carrying polylinker sequences, J. Mol. Biol., 170, 827, 10.1016/S0022-2836(83)80190-9

Karn, 1980, Novel bacteriophage cloning vector, 77, 5172

Benton, 1977, Screening Xgt recombinant clones by hybridization to single plaques in situ, Science, 196, 180, 10.1126/science.322279

Maxam, 1980, Sequencing end-labeled DNA with base-specific chemical cleavages, Methods Enzymol., 65, 499, 10.1016/S0076-6879(80)65059-9

Prochownik, 1983, Isolation of a cDNA clone for human antithrombin III, J. Biol. Chem., 258, 8389, 10.1016/S0021-9258(20)82077-8

Prochownik, 1983, Molecular heterogeneity of inherited antithrombin III deficiency, New England J. Med., 308, 1549, 10.1056/NEJM198306303082601

Prochownik, 1985, Intron structure of the human antithrombin III gene differs from that of other members of the serine protease inhibitor superfamily, J. Biol. Chem., 260, 9608, 10.1016/S0021-9258(17)39280-3

Sakuragawa, 1983, Antithrombin III Toyama : a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis, Thromb. Res., 31, 305, 10.1016/0049-3848(83)90333-X

Girolami, 1985, Antithrombin III (AT III) Padua 2 : A “new” congenital abnormality with defective heparin cofactor activities but no thrombotic disease, Blut, 47, 93, 10.1007/BF02482643

Girolami, 1983, Antithrombin III Padua: A “new” congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease, Folia Haematol., 110, 98

Penner, 1979, A clinically silent antithrombin III defect in an Ann Arbor family, Thromb. Haemost., 42, 186

Borg, 1985, Antithrombines III anormales avec anomalie de liaison a l'heparine : incidence thrombotique faible, Nouvelle. Rev. Frank. d'Hematol., 27, 106

FISCHER, A.M., CORNU, P., STENBERG, C, MERIANE, F., DAUTZENBERG, M.D., CHAFFA, O., BEGUIN, S. and DESNOS, M. Antithrombin III Alger: a new homozygous AT III variant. Thromb. Haemostas, in the press.

Boyer, 1985, Antithrombine III Fontainebleau: un variant homozygote de l'antithrombine III, Nouvelle Rev. Frank. d'Hematol., 27, 106

Tran, 1980, Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis, Thromb. Haemost., 44, 87, 10.1055/s-0038-1650090

Fischer, 1983, A new case of abnormal antithrombin III (AT III) : biological characteristics and thromboembolic accidents management, Thromb. Haemost., 50, 1124

Wolf, 1982, A new familial variant of antithrombin III: “Antithrombin III Paris”, Brit. J. Haematol., 51, 285, 10.1111/j.1365-2141.1982.tb02782.x